| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 26, 2007
Accepted on December 17, 2007
Diabetes Branch (G.Z., J.E., M.M.R., N.B.), NIDDK, National Institutes of Health, Bethesda, Maryland 20892 and Department of Cancer Pathways (C.E., J.G.), Merck Research Laboratories, Boston, MA 02115
* To whom correspondence should be addressed. E-mail: mrechler{at}helix.nih.gov.
IGF-binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells directly without sequestering IGF-I and IGF-II. The molecular mechanisms responsible for the IGF-independent actions of IGFBP-3 remain unclear. IGFBP-3, a secreted protein, can be internalized and translocate to the nucleus. It binds to the nuclear retinoid receptor RXR-
. Binding to RXR-
has been proposed to be required for IGFBP-3 to induce apoptosis. The present study tests this hypothesis in PC-3 human prostate cancer cells. PC-3 cells express RXR-
, and apoptosis is induced by incubation with RXR-specific ligand. A COOH-terminal region in IGFBP-3 (residues 215–232) contains a nuclear localization signal (NLS) and binding domains for RXR-
and heparin (HBD). Different combinations of the 11 amino acids in this region that differ from IGFBP-1, a related IGFBP which does not localize to the nucleus or bind RXR-
, were mutated to the IGFBP-1 sequence. By confocal imaging, mutation of residues 228-KGRKR-232 in nonsecreted IGFBP-3 diminished its nuclear localization. IGFBP-3 binding to GST-RXR-
only was lost when all 11 sites were mutated (HBD-11m-IGFBP-3). Expressed nuclear RXR-
did not transport cytoplasmic IGFBP-3 NLS mutants that can bind RXR-
to the nucleus even after treatment with RXR-ligand. Expressed HBD-11m-IGFBP-3 still induced apoptosis in PC-3 cells in an IGF-independent manner as determined by flow cytometric analysis of Annexin V staining. We conclude that in PC-3 cells RXR-
is not required for the nuclear translocation of IGFBP-3, and that IGFBP-3 can induce apoptosis in human prostate cancer cells without binding RXR-
.
Apoptosis
Human Prostate Cancer Cells
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |